3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
19
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myeloproliferative Disorders
4
Recurrence
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Neuroblastoma
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hematologic Neoplasms
2
Transplant-Related Hematologic Malignancy
1
Teratoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Neoplasms by Histologic Type
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell
1
Interventions
Temozolomide
5
Specimen Handling
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
vocimagene amiretrorepvec
1
trametinib
1
dabrafenib
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Outcome Assessment, Health Care
1
Observational Studies as Topic
1
Ketoconazole
1
Irinotecan
1
Heart Rate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
DNA
1
Craniotomy
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
Granulocyte Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.